Cite
Genomic analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy
MLA
Shilpa Gupta, et al. “Genomic Analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of Nivolumab, Gemcitabine, and Cisplatin in Patients with MIBC Undergoing Cystectomy.” Journal of Clinical Oncology, vol. 41, Feb. 2023, p. 559. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4a6b524cfe4e6bfffffcafbd4bc5ad2d&authtype=sso&custid=ns315887.
APA
Shilpa Gupta, Vladimir Makarov, Guru P. Sonpavde, Ewan Gibb, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Matthew Mossanen, Bharat Thyagarajan, C. Marcela Diaz-Montero, Prerana Parthasarathy Bangalore, & Badrinath R. Konety. (2023). Genomic analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy. Journal of Clinical Oncology, 41, 559.
Chicago
Shilpa Gupta, Vladimir Makarov, Guru P. Sonpavde, Ewan Gibb, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, et al. 2023. “Genomic Analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of Nivolumab, Gemcitabine, and Cisplatin in Patients with MIBC Undergoing Cystectomy.” Journal of Clinical Oncology 41 (February): 559. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4a6b524cfe4e6bfffffcafbd4bc5ad2d&authtype=sso&custid=ns315887.